注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Daiichi Sankyo Co Ltd是一家主要從事藥品生產和銷售業務的日本公司。該公司從事藥物的研究、開發、製造和銷售業務,並在日本、美國、歐洲和其他市場提供藥物生產的中間體和基礎材料。該公司還從事非處方藥和疫苗的研究、開發、生產和銷售業務,提供人力資源和會計服務等行政服務,以及從事房地產租賃和保險代理業務。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Sawako Nohara | 65 | 2019 | Independent Outside Director |
Masako Watanabe | 61 | 2021 | Outside Audit & Supervisory Board Member |
Sunao Manabe | 69 | 2009 | Group CEO & Executive Chairperson |
Yukiko Imazu | 55 | 2018 | Outside Audit & Supervisory Board Member |
Kama Kazuaki | 75 | 2019 | Independent Outside Chairperson |
Miyuki Arai | 60 | 2019 | Member of Audit & Supervisory Board |
Yasuhiro Komatsu | 66 | 2022 | Independent Outside Director |
Mitsuhiro Matsumoto | 62 | 2022 | Outside Audit & Supervisory Board Member |
Kenji Sato | 60 | 2019 | Chairman of Audit & Supervisory Board |
Takaaki Nishii | 64 | 2023 | Independent Outside Director |
Shoji Hirashima | 62 | 2017 | Senior Managing Executive Officer, Head of Japan Business Unit & Representative Director |
Masahiko Ohtsuki | 64 | 2014 | Senior Managing Exec. Officer, Head of Global DX, Chief Digital Transformation Officer & Director |
Hiroyuki Okuzawa | 61 | 2018 | President, COO & Representative Director |
Takashi Fukuoka | 63 | 2022 | Senior Managing Exec. Officer, Global Head of Corporate Strategy, Chief Strategy Officer & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核